ROMANO KATHRYN

PrivateCIK: 1801385
Location

PITTSBURGH, PA

ROMANO KATHRYN (Chief Accounting Officer) sold 3.2% of their position (750.00 shares) of KRYSTAL BIOTECH, INC. on the open market

Open‑market sale worth $200.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderROMANO KATHRYNCIK 1801385
IssuerKRYSTAL BIOTECH, INC.CIK 1711279
Officer· Chief Accounting Officer
Since Jan 2020
+14.77K
Net shares
Net buyer
$1.17M
Total sold
1
Open market trades
0B · 1S
9
Total transactions
27.07K acquired · 12.30K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+7.50K

Price / share

Trade value

% of position

40.4%
2/27/2026
18.57K26.07K

Common Stock

Direct
F · Tax Withholding

Shares

3.26K

Price / share

$275.64

Trade value

$899.14K

% of position

12.5%
2/27/2026
26.07K22.81K

Common Stock

Direct
M · Option Exercise

Shares

+550.00

Price / share

Trade value

% of position

2.4%
2/27/2026
22.81K23.36K

Common Stock

Direct
F · Tax Withholding

Shares

240.00

Price / share

$275.64

Trade value

$66.15K

% of position

1.0%
2/27/2026
23.36K23.12K

Common Stock

Direct
S · Sale

Shares

750.00

Price / share

$267.60

Trade value

$200.70K

% of position

3.2%
3/2/2026
23.12K22.37K
Total

Net shares

+3.80K

Net value

-$1.17M

Derivative Transactions4

Performance Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

7.50K shares

Shares

7.50K

Strike price

Held after

0.00

Exercisable

2/27/2026

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

550.00 shares

Shares

550.00

Strike price

Held after

1.65K

Exercisable

2/27/2026

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

13.57K shares

Shares

+13.57K

Strike price

275.64

Held after

13.57K

Exercisable

2/27/2026

Restricted Stock Units

Direct
A · Award
Converts to

Common Stock

5.44K shares

Shares

+5.44K

Strike price

Held after

5.44K

Exercisable

2/27/2026
ROMANO KATHRYN — Insider Transaction (Form 4) Filed Mar 3, 2026 | Finecho